Summary
Atherosclerotic lesions are composed of cellular elements that have migrated from the vessel lumen and wall to form the cellular component of the developing plaque. The cellular elements are influenced by various growth-regulatory molecules, cytokines, chemoattractants, and vasoregulatory molecules that regulate the synthesis of the extracellular matrix composing the plaque. Because vascular smooth muscle cells (VSMC) constitute the major cellular elements of the atherosclerotic plaque and are thought to be responsible for the extracellular matrix that becomes calcified in mature plaques, immunostaining for collagenous and noncollagenous proteins typically associated with bone matrix was conducted on VSMC grownin vitro. VSMC obtained from human aorta were grown in chambers on glass slides and immunostained for procollagen type I, bone sialoprotein, osteonectin, osteocalcin, osteopontin, decorin, and biglycan. VSMC demonstrated an intense staining for procollagen type I, and a moderately intense staining for the noncollagenous proteins, bone sialoprotein and osteonectin, two proteins closely associated with bone mineralization. Minimal immunostaining was noted for osteocalcin, osteopontin, decorin, and biglycan. The presence in VSMC of collagenous and noncollagenous proteins associated with bone mineralization suggest that the smooth muscle cells in the developing atherosclerotic plaque play an important role in the deposition of the extracellular matrix involved in calcification of developing lesions.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abraham, P. A.; Smith, D. W.; Carnes, W. H. Synthesis of soluble elastin by aortic medial cells in culture. Biochem. Biophys. Res. Commun. 58:597–604; 1974.
Ang, A. K.; Tachas, G.; Campbell, J. H., et al. Collagen synthesis by cultured rabbit aortic smooth muscle cells: Alteration with phenotype. Biochem. J. 265:461–469; 1990.
Asundi, V.; Cowan, K.; Matzura, D., et al. Characterization of extracellular matrix proteoglycan transcripts expressed by vascular smooth muscle cells. Eur. J. Cell Biol. 52:98–104; 1990.
Bianco, P.; Fisher, L. W.; Young, M. F., et al. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J. Histochem. Cytochem. 38:1549–1563; 1990.
Bianco, P.; Riminucci, M.; Silvestrini, G., et al. Localization of bone sialoprotein (BSP) to Golgi and post-Golgi secretory structures in osteoblasts and to discrete sites in early bone matrix. J. Histochem. Cytochem. 41:193–203; 1993.
Bolander, M. E.; Robey, P. G.; Fisher, L. W., et al. Monoclonal antibodies against osteonectin show conservation of epitopes across species. Calcif. Tissue Int. 45:74–80; 1989.
Bostrom, K.; Watson, K. E.; Horn, S., et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J. Clin. Invest. 91:1800–1809; 1993.
Burleigh, M. C.; Briggs, A. D.; Lendon, C. L., et al. Collagen types I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: Span-wise variation. Atherosclerosis 96:71–81; 1992.
Campbell, J. H.; Kalevitch, S. G.; Rennick, R. E., et al. Extracellular matrix-smooth muscle phenotype modulation by macrophages. Ann. NY Acad. Sci. 598:159–166; 1990.
Carlström, D.; Engfeldt, B.; Engström, B., et al. Studies on the chemical composition of normal and abnormal blood vessel walls. I. Chemical nature of vascular calcified deposits. Lab. Invest. 2:325–335; 1953.
Chen, J. K.; Shapiro, H. S.; Sodek, J. Developmental expression of bone sialoprotein mRNA in rat mineralized connective tissues. J. Bone Miner. Res. 7:987–997; 1992.
Chen, J. K.; Shapiro, H. S.; Wrabam, J. L., et al. Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization. Matrix 11:133–143; 1991.
Fisher, L. W. The nature of proteoglycans in bone. In: Butler, E. T., ed. The chemistry and biology of mineralized tissues. Birmingham, AL: EBSCO Media; 1985:188–196.
Fisher, L. W.; Hawkins, G. R.; Tuross, N., et al. Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. J. Biol. Chem. 262:9702–9708; 1987.
Fisher, L. W.; Termine, J. D.; Young, M. F. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem. 264:4571–4576; 1989.
Fisher, L. W.; Whitson, S. W.; Avioli, L. V., et al. Matrix sialoprotein of developing bone. J. Biol. Chem. 258:12723–12727; 1983.
Giachelli, C. M.; Bae, N.; Almeida, M., et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 92:1686–1696; 1992.
Gibbons, G. H.; Dzau, V. J. The emerging concept of vascular remodeling. N. Engl. J. Med. 330:1431–1438; 1994.
Gorski, J. P. Acidic phosphoproteins from bone matrix: A structural rationalization of their role in mineralization. Calcif. Tissue Int. 50:391–396; 1992.
Herman, I. M. Endothelial cell matrices modulate smooth muscle growth, contractile phenotype and sensitivity to heparin. Haemostasis 20:166–177; 1990.
Hirota, S.; Imakita, M.; Kohri, K., et al. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: A possible association with calcification. Am. J. Pathol. 143:1003–1008; 1993.
Ikeda, T.; Shirasawa, T.; Esaki, Y., et al. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J. Clin. Invest. 92:2814–2820; 1993.
Ingram, R.; Clarke, B.; Fisher, L., et al. Distribution of noncollagenous matrix proteins in the extracellular matrix of adult human bone: Evidence of anatomical and functional heterogeneity. J. Bone Miner. Res. 8:1019–1029; 1993.
Kasai, R.; Avioli, L. V.; Noguchi, A., et al. Distribution and regulation of an anti-proBGP cross-reacting protein in human serum, osteosarcoma and normal cells, and fetal bone. J. Bone Min. Res. 4:S247; 1989.
Kaufmann, J.; Jorgensen, R. W.; Martin, B. M., et al. Monocyte activation by smooth muscle cell-derived matrices. Atherosclerosis 85:113–125; 1990.
Lian, J. B.; Tassinari, M.; Glowacki, J. Resorption of implanted bone prepared from normal and warfarin-treated rats. J. Clin. Invest. 73:1223–1226; 1984.
Liptay, M. J.; Parks, W. C.; Mecham, R. P., et al. Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J. Clin. Invest. 91:588–594; 1993.
Majesky, M. W.; Lindner, V.; Twardzik, D. R., et al. Production of transforming growth factor β1 during repair of arterial injury. J. Clin. Invest. 88:904–910; 1991.
Majors, A. K.; Ehrhart, L. A. Cell density and proliferation modulate collagen synthesis and procollagen mRNA levels in arterial smooth muscle cells. Exp. Cell Res. 200:168–174; 1992.
McKee, M.; Glimcher, M.; Nanci, A. High resolution immunolocalization of osteopontin and osteocalcin in bone and cartilage during endochondral ossification in the chicken tibia. Anat. Rec. 234:479–492; 1992.
Murata, K.; Motoyama, T. Collagen species in various sized human arteries and their changes with intimal proliferation. Artery 17:96–106; 1990.
Ross, R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 363:801–809; 1993.
Shanahan, C. M.; Cary, N. R. B.; Metcalfe, J. C., et al. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J. Clin. Invest. 93:2393–2402; 1994.
Stary, H. C. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur. Heart J. 11 (Suppl. E):3–19; 1990.
Tabas, I.; Li, Y.; Brocia, R. W., et al. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix: A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation. J. Biol. Chem. 268:20419–20432; 1993.
Tan, E. M.; Glassberg, E.; Olsen, D. R., et al. Extracellular matrix gene expression by human endothelial and smooth muscle cells. Matrix 11:380–387; 1991.
Termine, J. D.; Kleinman, H. K.; Whitson, S. W., et al. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26:99–105; 1981.
Thie, M.; Harrach, B.; Schonherr, E., et al. Responsiveness of aortic smooth muscle cells to soluble growth mediators is influenced by cell-matrix contact. Arterioscler. Thromb. 13:994–1004; 1993.
Watson, K. E.; Bostrom, K.; Ravindranath, R., et al. TGF-β1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J. Clin. Invest. 93:2106–2113; 1994.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Severson, A.R., Ingram, R.T. & Fitzpatrick, L.A. Matrix proteins associated with bone calcification are present in human vascular smooth muscle cells grownin vitro . In Vitro Cell Dev Biol - Animal 31, 853–857 (1995). https://doi.org/10.1007/BF02634569
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02634569